Late-Onset Pneumocystis Jirovecii Pneumonia Post-Allogeneic Stem Cell Transplantation after Completion of Time Dependent Prophylaxis and COVID Pneumonia: A Case Report

Key Points

• Pneumocystis jirovecii pneumonia presented late after allogeneic stem cell transplantation.
• The patient developed COVID pneumonia, indicating possible immunocompromised status underlying risks.
• Case report highlights the significance of continuous monitoring even after prophylaxis has been completed.
• Further attention required on the timing and management of prophylactic treatments in similar patient populations.